Tokyo Tape
Sign in
← AuBEX

Quarterly report · Q3

3583.TEDINET S100Q49V
Period2022-04-01 → 2022-12-31
Filed2023-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥4.0bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥5.5bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥4.1bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥507m2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥558m2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥519m2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥727m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥563m2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥561m2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥563m2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥365m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥537m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥395m2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥365m2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥395m2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥9.5bnat 2022-12-31Cons.Assets
Total assets¥9.4bnat 2022-03-31Cons.Assets
Total assets¥9.3bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥3.8bnat 2022-12-31Cons.Liabilities
Total liabilities¥4.0bnat 2022-03-31Cons.Liabilities
Net assets / equity¥5.7bnat 2022-12-31Cons.Net assets
Net assets / equity¥5.4bnat 2022-03-31Cons.Net assets
Net assets / equity¥5.2bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥2.6bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥2.5bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥131.722022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥34.342022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥194.042021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥142.82021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥51.612021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio60.3%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio57.4%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio56.2%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥18m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥344,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥18m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31−¥6m
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥3m
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥73m
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥2.9bn
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥2.9bn
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥669m
—segment totalrevenue2022-04-01 → 2022-12-31¥4.0bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥4.0bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥3m
—segment totalsegment profit2022-04-01 → 2022-12-31¥741m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥4.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥4.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥21m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥735m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-12-31¥8m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-12-31¥2m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-12-31¥6m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-12-31−¥17m
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue2021-04-01 → 2021-12-31¥1.0bn
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue external2021-04-01 → 2021-12-31¥1.0bn
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥3m
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentsegment profit2021-04-01 → 2021-12-31¥112m
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentrevenue2021-04-01 → 2021-12-31¥3.0bn
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentrevenue external2021-04-01 → 2021-12-31¥3.0bn
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentsegment profit2021-04-01 → 2021-12-31¥689m
—segment totalrevenue2021-04-01 → 2021-12-31¥4.1bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥4.1bn
—segment totalrevenue intersegment2021-04-01 → 2021-12-31¥3m
—segment totalsegment profit2021-04-01 → 2021-12-31¥801m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥4.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥4.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥9m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥784m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 378
ItemContextValueUnit
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E00584-000MedicalProductsReportableSegmentsMember3227000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember3227000JPY
Transactions with other segmentsPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember6000000JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember9227000JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E00584-000TechnologicalProductsReportableSegmentsMember3031369000JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E00584-000MedicalProductsReportableSegmentsMember1045823000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember4077192000JPY
Net salesPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember7626000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember4084818000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q3r_E00584-000TechnologicalProductsReportableSegmentsMember688716000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q3r_E00584-000MedicalProductsReportableSegmentsMember112240000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember800957000JPY
Operating incomePrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-16846000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember784110000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q3r_E00584-000TechnologicalProductsReportableSegmentsMember2907611000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q3r_E00584-000MedicalProductsReportableSegmentsMember1057414000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember3965025000JPY
Revenues from external customersCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember344000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember3965370000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E00584-000TechnologicalProductsReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E00584-000MedicalProductsReportableSegmentsMember3428000JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember3428000JPY
Transactions with other segmentsCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember18000000JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember21428000JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E00584-000TechnologicalProductsReportableSegmentsMember2907611000JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E00584-000MedicalProductsReportableSegmentsMember1060842000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember3968454000JPY
Net salesCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember18344000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember3986799000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E00584-000TechnologicalProductsReportableSegmentsMember668734000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E00584-000MedicalProductsReportableSegmentsMember72687000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember741421000JPY
Operating incomeCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-6021000JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember735400000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-02-09
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第138期第３四半期(自 2022年10月１日 至 2022年12月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)オーベクス株式会社
Company name in english cover pageFilingDateInstantAuBEX CORPORATION
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長 栗 原 則 義
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都墨田区両国四丁目31番11号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03(6701)3200(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役管理部長 塚 越 孝 弘
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都墨田区両国四丁目31番11号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03(6701)3200(代表)
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役管理部長 塚 越 孝 弘
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE00584

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass